This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Chris Macri: Innovator in Pharmaceutical Compositions
Introduction
Chris Macri is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on glycogen phosphorylase inhibitors. His expertise and dedication to research have led to the development of valuable compositions that can impact medical treatments.
Latest Patents
Chris Macri holds 1 patent for his invention titled "Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor." This patent discloses pharmaceutical compositions that are particularly effective in delivering a sparingly soluble glycogen phosphorylase inhibitor. The patent also outlines methods for creating these compositions and the dosage forms derived from them.
Career Highlights
Chris Macri is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative drug formulations.
Collaborations
Throughout his career, Chris has collaborated with talented professionals, including Marshall David Crew and Dwayne Thomas Friesen. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical science.
Conclusion
In summary, Chris Macri is a dedicated inventor whose work in pharmaceutical compositions has the potential to make a significant impact in the medical field. His contributions, particularly in glycogen phosphorylase inhibitors, highlight the importance of innovation in healthcare.